Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis

• Published in: PloS one Vol. 17; no. 11; p. e0276774
• Main Authors: Uruma, Yuka, Manabe, Toshie, Fujikura, Yuji, Iikura, Motoyasu, Hojo, Masayuki, Kudo, Koichiro
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.11.2022; Public Library of Science (PLoS)
• Subjects: Asthma; Asthma - epidemiology; Chronic obstructive pulmonary disease; Cohort analysis; Comorbidity; Complications and side effects; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - mortality; COVID-19 - therapy; Health risks; Humans; Lung diseases; Lung diseases, Obstructive; Medicine and Health Sciences; Meta-analysis; Mortality; Mortality risk; Obstructive lung disease; Patients; People and Places; Physical Sciences; Prevalence; Pulmonary Disease, Chronic Obstructive - epidemiology; Research and Analysis Methods; Risk Assessment; Japan; Netherlands; United Kingdom > UK; United States > US; China

The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mor...